|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/02 | (2006.01) |
| A61K 47/10 | (2017.01) | ||
| A61K 38/26 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3810201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19739766.4 |
| Date of filing the European patent application | 2019-06-14 | |
| (97) | Date of publication of the European application | 2021-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation | 2023-07-25 |
| (86) | Number | PCT/US2019/037146 |
| Date | 2019-06-14 |
| (87) | Number | WO 2019/245893 |
| Date | 2019-12-26 |
| (30) | Number | Date | Country code |
| 201862688632 P | 2018-06-22 | US |
| (72) |
CORVARI, Vincent John , US
MINIE, Christopher Sears , US
MISHRA, Dinesh Shyandeo , US
QIAN, Ken Kangyi , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | GlP/GLP1 agonistų kompozicijos |
| GIP/GLP1 AGONIST COMPOSITIONS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 7 | 162.00 EUR |
| 2026-06-14 |